ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
3,1,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
5,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
7,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
12,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Eye allergy,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
16,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
18,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
19,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,2,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
22,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
24,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
25,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
26,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
28,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
28,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
31,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
33,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
34,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
35,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
37,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
37,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
38,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
39,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
44,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
47,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
47,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
47,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
52,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
53,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
54,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
54,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
55,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
55,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
57,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
58,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
59,1,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
60,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
60,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
61,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
62,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
64,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
66,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
67,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
68,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
69,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
70,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
70,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
71,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
72,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
73,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
74,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
74,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,1,Increased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
75,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
77,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
79,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
81,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
83,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
85,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
85,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
85,3,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
86,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
86,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
87,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
88,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
91,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
92,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
93,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
94,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
94,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
94,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
94,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
95,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
96,1,Deafness,Hearing losses,Hearing disorders,Ear,N
97,1,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
97,2,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
97,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
97,4,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
97,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
99,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
100,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
101,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
101,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
101,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
102,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
104,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
105,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
106,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
107,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
108,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
109,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
109,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
111,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
112,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
113,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
114,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
114,2,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
115,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
115,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
115,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
116,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
118,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
119,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
119,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
120,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
121,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
122,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
122,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
124,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
125,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
126,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
126,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
128,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
128,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
129,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
130,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
131,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
132,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
133,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
135,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
135,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
135,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
136,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
137,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
138,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
140,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
140,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
141,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
141,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
141,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
142,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
143,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
144,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
144,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
146,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
147,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
148,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
149,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
149,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
149,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
151,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
152,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
152,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
152,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
154,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
155,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
155,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
155,3,Myopathy,Myopathies,Muscle disorders,Musc,N
156,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
157,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
158,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
159,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
160,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
161,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
162,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
162,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
164,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
164,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
164,4,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
165,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
166,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
167,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
167,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
168,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
168,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
168,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
168,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
169,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
170,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
171,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
172,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
172,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
172,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
172,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
172,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
173,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
173,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
173,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
174,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
175,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
176,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
177,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
177,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
178,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
178,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
180,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
180,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
180,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
182,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
182,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
184,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
185,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
186,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
187,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
188,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
189,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
190,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
191,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
191,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
192,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
193,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
194,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
194,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
195,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
196,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
197,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
198,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
199,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
199,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
199,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
200,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
200,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
201,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
201,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
202,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
203,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
204,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
205,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
207,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
208,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
208,2,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
209,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
209,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
210,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
211,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
212,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
213,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
214,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
215,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
216,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
216,3,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
216,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
218,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
219,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
219,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
220,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
221,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
221,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
223,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
224,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
224,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
225,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
226,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
227,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
228,2,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
228,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
228,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
228,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
229,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
230,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
231,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
232,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
233,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
233,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
233,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
233,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
233,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
234,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
234,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
235,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
236,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
237,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
238,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
239,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
240,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
240,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
241,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
242,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
243,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
244,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
244,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
244,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
244,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
244,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
245,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
246,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
246,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
246,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
246,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
247,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
248,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
249,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
250,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
251,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
252,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
253,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
254,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
255,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
256,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
256,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
257,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
258,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
259,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
259,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,Y
260,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
260,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
261,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
262,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
263,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
264,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
265,1,Deafness,Hearing losses,Hearing disorders,Ear,N
266,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
267,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
268,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
269,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
270,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
271,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
271,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
272,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
272,2,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
272,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
272,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
273,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
273,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
274,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
275,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
276,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
277,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
277,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
279,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
281,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
281,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
281,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
281,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,6,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
282,1,Staphylococcal scalded skin syndrome,Staphylococcal infections,Bacterial infectious disorders,Infec,N
283,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
283,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
283,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
284,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
284,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
285,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
286,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
287,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
287,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
288,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
289,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
289,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
289,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
289,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
290,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
291,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
292,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
293,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
294,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
294,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
294,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
295,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
296,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
297,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
298,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
298,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
300,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
302,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
303,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
304,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
305,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
306,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
307,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
308,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
308,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
309,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
310,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
311,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
311,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
312,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
312,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
314,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
314,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
315,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
315,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
316,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
317,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
318,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
318,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
318,3,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
319,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
320,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
320,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
321,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
322,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
323,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
323,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
324,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
324,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
325,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
326,1,Bilirubinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
326,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
326,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
327,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
328,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
330,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
331,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
332,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
333,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
333,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
334,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
335,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
336,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
337,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
337,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
337,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
338,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
338,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
339,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
339,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
340,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
340,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
340,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
341,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
342,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
342,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
343,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
344,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
344,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
346,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
346,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
347,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
348,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
349,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
349,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
349,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
349,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
349,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
349,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
350,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
351,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
351,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
352,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
352,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
353,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
354,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
355,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
356,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
357,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
358,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
359,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
360,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
361,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
362,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
363,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
364,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
364,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
365,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
366,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
367,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
368,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
369,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
369,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
370,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
370,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
371,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
372,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
372,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
372,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
373,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
373,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
373,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
374,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
374,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
375,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
376,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
377,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
378,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
378,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
379,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
380,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
381,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
382,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
383,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
384,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
385,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
386,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
386,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
387,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
387,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
389,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
390,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
391,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
392,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
393,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
394,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
394,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
395,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
396,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
397,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
397,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
398,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
399,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
399,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
400,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
402,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
402,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
402,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
404,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
405,1,Headache,Headaches NEC,Headaches,Nerv,N
406,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
407,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
408,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
409,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
410,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
411,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
412,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
413,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
413,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
415,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
415,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
416,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
417,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
418,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
419,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
420,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
421,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
422,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
423,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
424,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
424,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
425,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
425,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
426,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
427,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
428,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
429,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
430,1,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
430,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
431,1,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
431,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
432,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
433,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
433,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
433,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
434,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
434,4,Headache,Headaches NEC,Headaches,Nerv,N
434,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
437,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
438,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
439,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
439,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
440,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
441,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
442,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
442,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
443,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
443,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
444,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
444,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
444,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
445,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
445,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
445,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
446,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
447,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
447,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
447,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
449,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
450,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
450,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
451,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
452,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
453,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
454,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
455,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
455,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
455,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
456,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
456,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
457,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
458,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
459,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
459,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
460,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
460,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
461,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
462,1,Headache,Headaches NEC,Headaches,Nerv,N
463,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
464,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
464,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
466,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
467,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
467,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
467,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
467,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
468,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
469,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
470,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
470,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
471,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
472,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
473,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
474,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
474,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
474,3,Myopathy,Myopathies,Muscle disorders,Musc,N
474,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
475,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
476,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
476,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
477,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
478,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
478,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
478,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
479,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
479,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
479,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
480,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
481,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
482,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
483,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
483,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
484,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
485,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
486,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
487,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
487,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
487,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
488,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
489,1,Pigmentation lip,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
490,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
490,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
490,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
490,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
491,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
491,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
491,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
492,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
492,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
493,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
493,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
494,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
495,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
495,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
496,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
496,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
497,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
498,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
499,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
500,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
500,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
501,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
502,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
503,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
503,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
504,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
504,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
505,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
505,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
506,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
506,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
507,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
508,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
508,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
508,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
508,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
509,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
510,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
510,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
511,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
511,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
512,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
512,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
513,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
514,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
514,2,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
514,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
514,4,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
514,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
514,6,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
515,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
515,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
515,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
516,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
516,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
516,4,Myopathy,Myopathies,Muscle disorders,Musc,N
517,1,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
518,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
518,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
519,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
521,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
521,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
521,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
521,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
521,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
522,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
522,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
522,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
523,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
524,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
524,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
524,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
524,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
525,1,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
526,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
527,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
527,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
528,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
528,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
529,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
529,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
530,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
530,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
530,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
530,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
530,5,Myopathy,Myopathies,Muscle disorders,Musc,N
530,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
531,1,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
531,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
532,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
532,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
532,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
533,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
534,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
534,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
535,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,1,Acute cholecystitis necrotic,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
536,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
536,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
537,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
538,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
538,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
539,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
539,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
539,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
539,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
540,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
540,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
540,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
541,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
541,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
541,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
541,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
541,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
541,7,Myopathy,Myopathies,Muscle disorders,Musc,N
541,8,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
542,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
542,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
543,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
543,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
543,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
543,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
543,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
543,7,Myopathy,Myopathies,Muscle disorders,Musc,N
543,8,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
543,9,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
544,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
544,2,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
544,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
544,4,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
544,5,Phimosis,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
544,6,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
545,1,Fontanelle bulging,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
545,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
546,1,Fontanelle bulging,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
546,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
547,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
547,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
547,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
547,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
548,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
548,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
548,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
549,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
549,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
550,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
551,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
551,2,Urine electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
552,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
553,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
553,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
553,4,Myopathy,Myopathies,Muscle disorders,Musc,N
554,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
554,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
555,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
556,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
556,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
556,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
556,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
556,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
556,7,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
556,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
557,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
557,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
558,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
558,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
559,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
559,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
559,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
559,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
559,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
559,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
559,7,Migraine,Migraine headaches,Headaches,Nerv,N
559,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
559,10,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
559,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,12,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
560,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
560,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
561,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
561,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
561,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
561,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
561,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
561,6,Diaphragmatic disorder,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
561,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,8,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
561,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
561,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
561,11,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
561,12,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
561,13,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
561,14,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
561,15,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
561,16,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
562,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
562,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
562,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
562,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
562,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
562,8,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
563,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
563,2,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
563,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
564,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
565,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
565,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
566,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
566,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
566,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
567,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
567,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
567,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
568,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
569,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
569,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
570,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
570,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
571,1,Conjunctivitis allergic,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
572,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
573,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
574,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
575,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
575,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
575,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
575,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
576,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
576,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
577,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,2,External fixation of fracture,Fracture treatments (excl skull and spine),Bone and joint therapeutic procedures,Surg,N
577,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
577,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
578,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
579,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
579,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
579,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
579,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
579,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
579,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
579,7,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
580,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
580,2,Myopathy,Myopathies,Muscle disorders,Musc,N
580,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
580,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
580,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
581,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
582,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
583,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
583,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
583,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
583,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
584,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
585,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
586,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
587,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
588,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
588,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
588,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
588,5,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
588,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
589,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
590,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,2,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
590,3,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
590,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
590,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
591,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,2,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
591,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
592,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
592,2,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
593,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
593,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
593,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
593,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
594,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
594,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
594,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
594,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
594,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
595,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
596,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
597,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
597,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
599,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
600,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
600,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
600,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
600,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
601,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
601,2,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
602,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
603,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
603,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
603,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
603,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
604,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
605,1,Adjustment disorder with anxiety,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
605,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
605,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
605,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
605,5,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
605,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
605,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
605,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
605,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
605,10,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
605,11,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
605,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
605,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
605,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
605,15,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
605,16,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
605,17,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
606,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
606,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
606,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
607,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
608,1,Disorder of orbit,Ocular disorders NEC,Eye disorders NEC,Eye,N
608,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
608,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
609,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
609,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
610,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
611,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
611,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
611,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
611,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
611,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
612,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
612,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
613,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
613,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
613,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
613,4,Myopathy,Myopathies,Muscle disorders,Musc,N
613,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
614,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
614,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
614,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
614,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
614,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
614,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
614,7,Myositis-like syndrome,Muscle infections and inflammations,Muscle disorders,Musc,N
614,8,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
615,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
615,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
615,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
615,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
616,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
616,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
616,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
616,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
616,5,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
616,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
616,9,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
616,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
616,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
616,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
616,13,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
616,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
616,15,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
616,16,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
616,17,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
616,18,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
616,19,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
616,20,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
616,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
617,1,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
617,2,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
617,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
617,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
617,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
617,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
617,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
617,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
617,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
617,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
619,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
619,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
620,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
620,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
620,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
620,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
621,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
621,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
621,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
623,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
623,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
624,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
625,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
625,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
626,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
626,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
627,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
627,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
628,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
628,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
629,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
629,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
630,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
630,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
631,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
631,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
631,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
631,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
631,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
632,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
632,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
632,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
632,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
632,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
633,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
634,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
634,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
634,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
634,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
634,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
635,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
635,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
635,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
635,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
636,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
636,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
636,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
636,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
636,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
637,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
637,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
638,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
638,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
638,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
638,5,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
638,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
638,7,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
639,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
639,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
639,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
639,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
640,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
640,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
640,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
641,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
641,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
641,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
642,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
642,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
642,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
643,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
644,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
645,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
646,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
646,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
646,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
646,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
646,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
647,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
648,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
649,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
650,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
650,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
651,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
651,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
652,1,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
652,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
652,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
653,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
653,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
653,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
654,2,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
654,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
654,4,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
654,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
654,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
654,7,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
654,8,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
654,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
654,10,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
654,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
654,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
655,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
655,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
655,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
655,4,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
655,5,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
655,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
655,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
655,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
655,9,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
656,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
656,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
657,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
657,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
657,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
658,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
659,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
660,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
660,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
660,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
660,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
660,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
660,7,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
661,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
661,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
661,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
661,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
661,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
661,6,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
661,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
662,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
662,2,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
662,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
662,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
662,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
662,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
662,7,Splenic embolism,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
662,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
663,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
664,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
664,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
665,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
665,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
665,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
666,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
668,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
669,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
670,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
670,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
671,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
671,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
672,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
672,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
672,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
672,4,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
672,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
672,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
673,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
674,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
674,4,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
674,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
674,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
674,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
674,8,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
675,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
675,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
676,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
676,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
676,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
677,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
678,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
678,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
678,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
679,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
680,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
680,2,Headache,Headaches NEC,Headaches,Nerv,N
680,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
681,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
681,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
681,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
681,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
682,1,Acne,Acnes,Skin appendage conditions,Skin,N
682,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
682,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
682,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
682,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
682,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
682,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
682,9,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
682,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
682,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
682,12,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
682,13,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
682,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
682,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,17,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
682,18,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
682,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
682,20,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
682,21,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
682,22,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
682,23,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
682,24,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
682,25,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
683,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
684,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
684,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
685,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
685,2,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
686,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
687,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
687,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
688,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
688,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
689,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
689,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
689,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,6,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
690,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
690,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
690,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
690,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
690,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
690,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
690,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
691,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
692,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
692,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
693,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
694,1,Eye allergy,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
695,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
696,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
697,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
697,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
697,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
697,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
697,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
697,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
697,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
697,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
698,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
699,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
700,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
700,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
700,3,Inflammation of wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
700,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
700,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
701,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
701,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
701,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
701,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
701,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
703,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
704,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
704,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
705,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
706,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
706,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
707,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
708,1,Headache,Headaches NEC,Headaches,Nerv,N
708,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
708,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
710,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
710,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
710,3,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
710,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
710,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
710,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
710,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
710,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
710,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
710,10,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
711,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
712,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
713,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
713,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
713,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
714,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
714,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
714,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
715,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
716,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
716,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
716,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
717,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
717,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
717,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
717,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
717,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
717,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
718,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
718,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
719,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
720,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
721,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
722,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
722,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
722,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
722,5,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
722,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
722,7,Lacrimation decreased,Lacrimation disorders,Eye disorders NEC,Eye,N
722,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
722,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
722,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
723,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
724,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
725,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
726,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
727,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
728,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
729,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
730,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
730,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
731,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
731,2,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
731,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
732,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
733,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
733,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
734,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
735,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
735,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
736,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
736,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
736,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
737,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
738,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
738,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
738,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
738,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
738,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
738,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
738,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
738,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
738,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
739,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
739,3,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
739,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
740,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
741,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
742,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
742,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
742,3,Deafness,Hearing losses,Hearing disorders,Ear,N
742,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
742,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
742,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
742,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
742,8,Tension headache,Headaches NEC,Headaches,Nerv,N
742,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
743,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
743,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
744,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
745,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
745,2,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
745,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
745,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
745,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
745,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
745,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
746,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
746,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
746,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
746,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
747,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
747,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,Y
748,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
748,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
748,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
748,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
748,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
748,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
748,8,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
748,9,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
748,10,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
748,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
748,12,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
748,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
748,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
748,15,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
748,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
748,17,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
748,18,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
748,19,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
749,1,Penile blister,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
750,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
750,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
750,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
750,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
750,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
751,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
751,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
751,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
752,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
753,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
754,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
755,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
755,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
755,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
755,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
756,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
756,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
756,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
756,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
757,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
758,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
758,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
759,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
760,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
760,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
760,3,Forced vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
760,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
760,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
761,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
761,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
761,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
761,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
761,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
761,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
761,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
761,8,Migraine with aura,Migraine headaches,Headaches,Nerv,N
761,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
761,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
761,11,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
761,12,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
762,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
763,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
763,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
763,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
764,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
764,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
764,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
764,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
764,5,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
764,6,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
765,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
766,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
766,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
767,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
767,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
767,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
767,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
767,6,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
767,7,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
767,8,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
767,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
768,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
769,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
769,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
770,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
770,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
770,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
770,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
771,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
771,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
771,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
772,1,Headache,Headaches NEC,Headaches,Nerv,N
773,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
773,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
774,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
774,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
774,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
774,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
775,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
776,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
776,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
777,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
777,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
778,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
778,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
778,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
779,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
780,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
781,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
781,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
782,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
782,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
782,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,4,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
782,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
782,6,Prostatic disorder,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
782,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
782,8,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
783,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
783,2,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
783,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
783,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
783,5,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
784,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
785,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
785,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
786,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
786,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
788,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
789,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
789,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
789,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
789,4,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
789,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
789,6,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
789,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
789,8,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
790,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
790,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
791,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
791,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
791,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
791,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
791,5,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
791,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
792,1,Headache,Headaches NEC,Headaches,Nerv,N
793,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
793,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
794,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
795,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
795,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
796,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
796,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
796,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
796,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
796,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
796,6,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
796,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
796,8,Headache,Headaches NEC,Headaches,Nerv,N
796,9,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
796,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
797,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
797,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
797,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
797,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
797,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
797,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
797,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
798,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
798,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
798,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
798,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
798,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
798,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
799,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
799,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
799,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
799,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
800,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
800,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
800,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
801,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
801,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
801,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
802,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
802,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
803,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
804,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
804,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
804,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
805,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
805,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
805,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
806,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
806,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
806,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
806,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
806,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
806,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
806,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
806,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
806,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
807,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
808,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
809,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
811,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
811,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
811,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
811,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
811,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
811,6,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
811,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
811,8,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
811,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
811,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
811,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
811,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
811,13,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
812,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
812,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
813,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
814,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
815,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
816,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
817,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
818,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
819,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
820,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
820,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
820,3,Application site scab,Application site reactions,Administration site reactions,Genrl,N
820,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
821,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
822,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
823,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
823,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
824,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
825,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
825,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
825,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
825,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
825,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
826,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
826,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
826,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
827,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
828,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
828,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
828,3,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
829,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
829,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
830,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
830,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
831,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
831,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
831,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
832,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
832,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
832,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
832,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
832,5,Headache,Headaches NEC,Headaches,Nerv,N
832,6,Skin discharge,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
833,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
834,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
835,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
835,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
835,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
836,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
836,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
836,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
836,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
836,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
837,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
838,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
839,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
840,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
840,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
841,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
841,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
841,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
841,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
842,1,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
842,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
842,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
843,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
844,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
845,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
845,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
845,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
845,4,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
845,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
845,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
845,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
846,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
846,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
847,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
847,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
848,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
848,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
849,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
849,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
849,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
849,4,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
849,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
851,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
853,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
853,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
853,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
853,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
853,5,Pregnancy with injectable contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
854,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
854,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
854,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
855,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
856,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
857,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
857,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
857,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
858,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
859,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
859,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
859,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
859,4,Myopathy,Myopathies,Muscle disorders,Musc,N
860,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
860,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
861,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
861,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
861,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
861,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
862,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
863,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
864,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
864,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
864,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
864,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
864,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
864,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
864,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,10,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
864,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
865,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
865,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
865,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
865,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
865,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
866,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
868,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
869,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
869,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
869,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
869,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
869,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
869,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
869,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
869,8,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
870,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
870,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
870,3,Headache,Headaches NEC,Headaches,Nerv,N
871,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
872,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
873,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
874,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
874,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
875,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
875,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
876,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
877,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
877,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
877,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
878,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
878,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
878,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
879,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
880,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
881,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
882,1,Acne,Acnes,Skin appendage conditions,Skin,N
882,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
882,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
882,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
882,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
882,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
882,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
882,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
882,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
882,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
882,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
882,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,13,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,15,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,16,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
882,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
882,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
882,19,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
883,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
883,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
883,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
883,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
883,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
883,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
883,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
883,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
883,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
883,10,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
884,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
884,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
884,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
884,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
884,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
884,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
884,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
884,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
884,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
885,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
886,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
886,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
886,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
886,4,Headache,Headaches NEC,Headaches,Nerv,N
886,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
886,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
887,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
887,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
887,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
888,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
888,2,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
888,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
888,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
888,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
888,6,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
889,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
889,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
890,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
890,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
890,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
890,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
891,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
892,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
892,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
893,1,Application site odour,Application site reactions,Administration site reactions,Genrl,N
893,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
893,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
893,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
893,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
893,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,7,Migraine,Migraine headaches,Headaches,Nerv,N
893,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
893,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
893,10,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
893,11,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
894,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
895,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
895,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
896,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
897,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
897,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
897,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
897,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
898,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
899,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
899,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
899,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
899,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
899,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
899,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
899,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
899,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
899,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
899,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
900,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
900,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
901,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
902,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
902,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
902,3,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
903,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
903,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
903,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
903,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
903,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
903,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
903,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
903,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
903,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
903,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
903,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
903,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
903,13,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
904,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
904,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
905,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
905,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
905,3,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
905,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
905,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
905,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
905,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
905,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
905,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
905,10,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
905,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
905,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
905,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
905,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
905,15,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
905,16,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
905,17,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
905,18,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
906,1,Erection increased,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
907,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
907,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
907,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
907,4,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
907,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
907,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
907,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
908,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
908,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
908,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
908,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
908,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
908,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
908,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
909,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
910,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
910,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
910,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
910,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
910,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
910,6,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
910,7,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
910,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
910,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
910,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
910,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
910,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
911,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
913,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
913,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
914,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
915,1,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
915,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
916,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
916,2,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
917,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,1,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
919,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
920,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
920,2,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
920,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
920,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
920,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
921,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
921,2,Headache,Headaches NEC,Headaches,Nerv,N
921,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
921,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
921,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
922,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
922,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
922,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
922,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
922,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
922,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
922,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
922,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
922,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
922,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
922,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
922,12,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
922,13,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
922,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
922,15,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
922,16,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
922,17,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
923,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
923,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
923,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
923,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
923,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
923,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
923,7,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
923,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
923,9,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
923,10,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
923,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
924,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
925,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
926,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
926,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
926,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
926,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
927,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
927,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
928,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
929,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
929,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
930,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
930,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
930,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
930,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
930,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
930,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
930,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
930,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
930,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
930,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
930,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
930,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
931,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
931,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
932,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
932,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
933,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
933,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
934,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
934,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
934,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
934,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
934,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
934,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
934,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
934,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
935,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
936,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
937,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
938,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
938,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
939,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
939,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
939,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
939,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
940,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
940,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
941,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
941,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
942,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
942,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
943,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
944,1,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
945,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
946,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
947,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
948,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
949,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
950,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
951,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
952,1,Skin test,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
953,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
953,2,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
954,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
954,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
955,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
955,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
955,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
956,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
956,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
956,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
956,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
956,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
956,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
956,7,Product advertising issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,8,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
956,9,Product intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
956,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
956,12,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
956,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
956,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
956,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
956,16,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
956,17,Urticaria aquagenic,Urticarias,Angioedema and urticaria,Skin,N
957,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
958,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
959,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
959,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
960,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
961,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
962,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
962,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
962,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
963,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
963,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
964,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
965,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
965,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
966,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
966,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
966,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
966,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
966,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
966,6,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
966,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
967,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
967,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
968,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
969,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
969,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
970,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
971,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
971,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
973,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
974,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
974,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
974,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
974,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
974,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
974,7,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
974,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
975,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
975,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
976,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
976,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
977,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
977,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
978,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
979,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
980,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
981,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
982,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
983,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
984,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
984,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
985,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
986,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
986,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
986,4,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
986,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
986,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
986,7,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
986,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
986,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
986,10,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
986,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
986,12,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
986,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
986,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
986,15,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
986,16,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
986,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
986,18,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
986,19,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
986,20,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,21,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,22,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
986,23,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
986,24,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
986,25,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
986,26,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,27,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,28,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
986,29,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
986,30,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
986,31,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
986,32,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
987,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
987,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
987,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
987,4,Epinephrine increased,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
987,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
987,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
987,7,Madarosis,Alopecias,Skin appendage conditions,Skin,N
987,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
987,9,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
987,10,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
987,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
987,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
987,13,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
987,14,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
987,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
987,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
987,17,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
987,18,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
987,19,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
987,20,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
987,21,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
987,22,Skin temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
987,23,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
987,24,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
987,25,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
987,26,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
988,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
989,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
990,1,Anal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
990,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
990,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
990,4,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
991,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
991,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
992,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
993,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
994,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
995,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
996,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
997,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
998,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
999,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
999,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1000,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1001,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1002,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1003,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1003,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1004,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1004,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1004,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1004,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1004,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1004,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1005,1,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
1006,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1006,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1006,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1006,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1006,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1006,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1006,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1006,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1006,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1007,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1008,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1008,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1008,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1008,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1009,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1009,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1009,3,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1009,4,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1009,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1009,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1009,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1009,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1009,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1009,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1009,11,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1009,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1009,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1009,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1009,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1009,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1010,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1010,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1011,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1012,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1012,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1013,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1014,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1014,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1015,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1016,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1017,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1017,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1018,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1019,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1020,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1021,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1021,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1022,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1023,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1025,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1026,1,Drug screen false positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1027,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1028,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1029,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1029,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1029,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1030,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1030,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1030,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1031,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1031,2,Vaginal odour,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1032,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1032,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1032,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1032,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1032,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1032,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1032,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1032,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1032,9,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1032,10,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1033,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1033,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1033,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1033,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1034,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1035,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1035,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1035,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1035,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1035,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1035,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1035,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1035,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1035,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1036,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1037,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1037,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1037,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
